Online citations, reference lists, and bibliographies.

Streptozotocin-Induced Diabetic Models In Mice And Rats.

Brian L. Furman
Published 2015 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Streptozotocin (STZ) is an antibiotic that produces pancreatic islet β-cell destruction and is widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed in this unit are protocols for producing STZ-induced insulin deficiency and hyperglycemia in mice and rats. Also described are protocols for creating animal models for type 2 diabetes using STZ. These animals are employed for assessing the pathological consequences of diabetes and for screening potential therapies for the treatment of this condition.
This paper references
10.2337/diab.39.3.348
Diabetes-Related Changes in Chromatin Structure of Brain, Liver, and Intestinal Epithelium
J M Hartnell (1990)
10.1016/j.atherosclerosis.2006.08.030
Diabetic atherosclerosis mouse models.
Kenneth K. Wu (2007)
10.1155/2008/704045
The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model
Ming Zhang (2008)
10.2337/diab.31.8.724
Induction of Insulin-dependent Diabetes by Streptozotocin Inhibition by Estrogens and Potentiation by Androgens
Sang Gi Paik (1982)
Elevated manganese concentration and arginase activity in livers of streptozotocin-induced diabetic rats.
Judith S. Bond (1983)
10.2337/diab.40.9.1157
Low-Dose Streptozocin-Induced Autoimmune Diabetes in Islet Transplantation Model
Lamont G. Weide (1991)
Retinal upregulation of inflammatory
J. E. Mancini (2013)
10.1002/0471141755.ph0547s40
Streptozotocin-induced diabetic models in mice and rats.
Kenneth K. Wu (2008)
The first (Basic Protocol 3) entails concurrent administration of nicotinamide to partially protect the βcells against STZ
Schein (1998)
10.1155/2015/752481
Characterisation of Pain Responses in the High Fat Diet/Streptozotocin Model of Diabetes and the Analgesic Effects of Antidiabetic Treatments
Frederika Maria Byrne (2015)
10.2337/diab.37.1.21
Low-Dose Streptozocin-Induced Diabetes in Mice: Electron Microscopy Reveals Single-Cell Insulitis Before Diabetes Onset
Victoria Kolb-Bachofen (1988)
10.1211/jpp.57.12.0007
Antidiabetic effect of a new peptide from Squalus mitsukurii liver (S-8300) in streptozocin-induced diabetic mice.
Fengjie Huang (2005)
10.1258/la.2010.010090
Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models
Michael C. Deeds (2011)
Animal models of type 2 diabetes with reduced pancreatic beta-cell mass.
Pellegrino Masiello (2006)
Retinal upregulation of inflammatory Animal Models of Disease 5
J E Mancini (2013)
Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.
Susan J. Zunino (1994)
10.2337/diab.26.10.916
Genetic Influence of the Streptozotocin-induced Insulitis and Hyperglycemia
Aldo A. Rossini (1977)
10.1055/s-2005-861370
Functional abnormalities in isolated arteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models.
Emil T. Brøndum (2005)
For further analysis of the OGTT, comparisons to baseline values in each group were made using a Friedman test with Dunn’s post hoc test: HFD/Veh
Victoria Chapman (2015)
10.2174/1573399810666140508121012
Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Bingxuan Wang (2014)
The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity.
Philip S. Schein (1967)
Streptozotocininduced pancreatic insulitis: New model of diabetes mellitus
A. A. Like (1976)
10.1097/00004872-200304000-00020
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
Paul Zoen Kit Chan (2003)
10.1681/ASN.2009070721
Mouse models of diabetic nephropathy.
F. C. Iii Brosius (2009)
10.1172/JCI118604
Increased atherosclerosis in streptozotocin-induced diabetic mice.
Vidya V Kunjathoor (1996)
Effect of pregerminated brown rice intake on diabetic neuropathy in streptozotocin-induced diabetic rats
S. Usuki (2007)
10.1002/0471142735.im0106s73
Parenteral injections.
John Donovan (2006)
10.3181/00379727-92-22455
Anesthesia
Edward B. Truitt (1956)
10.1111/jdi.12235
Modeling type 2 diabetes in rats using high fat diet and streptozotocin
Søs Skovsø (2014)
10.1053/meta.2000.17721
A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
Marques Reed (2000)
10.2337/diab.16.1.51
Light and Electron Microscopy of Lesions in Rats Rendered Diabetic with Streptozotocin
R. N. Arison (1967)
10.1002/dmr.5610030308
Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice.
Hubert Kolb (1987)
10.1002/0471142735.im0107s73
Blood collection.
John Donovan (2006)
10.1677/joe.1.06596
Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats.
Paz Vital (2006)
10.1152/ajprenal.90613.2008
Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.
Pengcheng Luo (2009)
Resistance of the rabbit to streptozocin
M. Lazar (1968)
10.2337/diab.39.11.1391
Characteristics of Learning and Memory in Streptozocin-Induced Diabetic Mice
James F. Flood (1990)
10.2337/diab.47.2.224
Experimental NIDDM: Development of a New Model in Adult Rats Administered Streptozotocin and Nicotinamide
Pellegrino Masiello (1998)
10.2337/diab.25.7.595
Studies on Streptozotocin Diabetes
Om P Ganda (1976)
10.1172/JCI106180
Diabetogenic action of streptozotocin: relationship of dose to metabolic response.
Alain F. Junod (1969)
10.2337/db10-0044
Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin
Marvin Lin (2010)
and proangiogenic markers in a model of neonatal diabetic rats fed on a high-fat-diet
10.2337/db05-1275
Recovery of islet beta-cell function in streptozotocin- induced diabetic mice: an indirect role for the spleen.
Dengping Yin (2006)
10.1016/j.seizure.2009.11.003
ATP-sensitive potassium channels contribute to the time-dependent alteration in the pentylenetetrazole-induced seizure threshold in diabetic mice
Mehdi Ghasemi (2010)
10.2119/2003-00016.Mabley
Inosine Protects Against the Development of Diabetes in Multiple-Low-Dose Streptozotocin and Nonobese Diabetic Mouse Models of Type 1 Diabetes
Jon G. Mabley (2003)
10.2337/diab.30.5.424
A Major Loss in Islet Mass and B-cell Function Precedes Hyperglycemia in Mice Given Multiple Low Doses of Streptozotocin
Vagn Bonnevie-Nielsen (1981)
10.1556/APhysiol.101.2014.4.2
Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review).
Asghar Ghasemi (2014)
10.3181/00379727-126-32401
Studies of the Diabetogenic Action of Streptozotocin.∗
Alain Junod (1967)



This paper is referenced by
10.3390/biom10020201
Potential Antidiabetic Activity of Extracts and Isolated Compound from Adenosma bracteosum (Bonati)
Ngoc Khoi Nguyen (2020)
10.1038/s41598-018-35653-4
BET Inhibition Improves NASH and Liver Fibrosis
Sarah A Middleton (2018)
10.1515/JBCPP-2019-0061
Phytochemicals and antidiabetic activity of the aqueous extract of the Punica granatum fruit in streptozotocin-induced diabetic mice
Hải Nguyễn Thanh (2019)
10.13057/NUSBIOSCI/N090311
Topical treatment of ointment containing ethanol extract of Archidendron pauciflorum fruit peel on the wound healing in streptozotocin-induced diabetic mice
Desak Made Malini (2017)
10.3109/0886022X.2014.900404
The effects of adenosine A2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy
Leena Patel (2014)
10.1016/j.jtemb.2018.08.009
Profile of three boron-containing compounds on the body weight, metabolism and inflammatory markers of diabetic rats.
Yessica López-Cabrera (2018)
10.1016/j.compbiomed.2019.03.028
Rapid automatic identification of parameters of the Bergman Minimal Model in Sprague-Dawley rats with experimental diabetes for adaptive insulin delivery
Ana Gabriela Gallardo-Hernández (2019)
10.1556/650.2019.31455
Az extrém alacsony születési súlyú koraszülöttek hyperglykaemiájának korai és késői szövődményei
Réka Turai (2019)
Method for regulating and controling glp-1/glp-1r and drug
李季南 (2018)
10.1117/12.2563192
The study of spectral changes in THz range in normal and pathological skin in vivo depending on the dehydration methods used
Irina Yu. Yanina (2020)
10.3389/fimmu.2017.01671
Dendritic Cells Transduced with Single Immunoglobulin IL-1-Related Receptor Exhibit Immature Properties and Prolong Islet Allograft Survival
Zhicheng Xue (2017)
10.1038/srep27925
Cardiomyocyte GTP Cyclohydrolase 1 Protects the Heart Against Diabetic Cardiomyopathy
Hsiang-en Wu (2016)
10.6061/clinics/2013(10)11
The protective effect of aqueous extracts of roselle (Hibiscus sabdariffa L. UKMR-2) against red blood cell membrane oxidative stress in rats with streptozotocin-induced diabetes
Jamaludin Mohamed (2013)
10.1007/s12149-020-01495-2
Visualization of translocator protein (18 kDa) (TSPO) in the retina of diabetic retinopathy rats using fluorine-18-DPA-714
Yujing Zhou (2020)
10.13057/nusbiosci/n090312
Kidney histology in streptozotocin-induced diabetic male Wistar rats treated with combined extract of temulawak rhizome and belimbing wuluh fruit
Kartiawati Alipin (2017)
10.35248/2161-0940.19.9.316
Effect of Enriched Environment on the Cognitive and Behavioural Changes in the Streptozotocin-Induced Young Diabetic Rats
R. Rajashree (2019)
10.4103/ABR.ABR_65_19
Renal Tissue Damages and Its Antioxidant Status Improved by Crab Shell Extract in Streptozotocin-induced Diabetic Rat
Zohreh Ebrahimi (2019)
10.20510/ukjpb/3/i2/89330
Effects of Atorvastatin and Streptozocin on Immunohistochemical Markers in Hippocampus of Male Adult Rats
Mustafa Ghazi Al-abbassi (2015)
10.22038/IJBMS.2019.39582.9387
The effect of human wharton’s jelly-derived mesenchymal stem cells on MC4R, NPY, and LEPR gene expression levels in rats with streptozotocin-induced diabetes
Fatemeh Sabet Sarvestani (2020)
10.1186/s12906-019-2646-x
Glucose-lowering and hypolipidemic activities of polysaccharides from Cordyceps taii in streptozotocin-induced diabetic mice
Ru-ming Liu (2019)
Potential oral wound healing of topical application of dental gel prepared from baccaurea angulata fruit in diabetic rats
Omar Abdul Jabbar Abdul Qader (2017)
10.1016/j.jep.2019.112264
Reduction of blood glucose by plant extracts and their use in the treatment of diabetes mellitus; discrepancies in effectiveness between animal and human studies.
Brian L. Furman (2019)
10.1016/J.NUT.2019.05.007
Arachidonic acid-rich ARASCO oil has anti-inflammatory and antidiabetic actions against streptozotocin + high fat diet induced diabetes mellitus in Wistar rats.
Naveen K V Gundala (2019)
10.1016/j.biopha.2017.08.098
A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin.
Sevda Gheibi (2017)
10.4103/2278-344X.173889
Anti-diabetic activity of Shilajatvadi Lauha, an Ayurvedic traditional herbo-mineral formulation
Thakur Rakesh Singh (2016)
10.1002/jbt.22451
Lansoprazole enhances the antidiabetic effect of dapagliflozin in fortified diet-fed streptozotocin-treated diabetic rats.
Noha M Gamil (2020)
10.3390/cells9020481
The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus
Srinivas Pittala (2020)
10.1155/2016/8483537
Heart Rate Variability as Early Biomarker for the Evaluation of Diabetes Mellitus Progress
Rosa Elena Arroyo-Carmona (2016)
10.9734/JABB/2017/34101
Effect of Pomegranate Peel Extract on Submandibular Salivary Glands of Streptozotocin-Induced Diabetes in Rats: Histological, Immunohistochemical and Ultrastructural Study
Elham Fathy Mahmoud (2017)
10.12688/f1000research.22198.1
The Continuing Evolution of Insulin-like Growth Factor Signaling
Steven A. Rosenzweig (2020)
DB170249 2511..2520
Jiucheng He (2017)
10.3390/biology9010006
The Biological Impacts of Sitagliptin on the Pancreas of a Rat Model of Type 2 Diabetes Mellitus: Drug Interactions with Metformin
Lamiaa M. Shawky (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar